HUTCHMED (China) (HMDCF) Shares Outstanding (Diluted Average) (2014 - 2025)
HUTCHMED (China) (HMDCF) reported Shares Outstanding (Diluted Average) of $112.2 million for Q4 2025, little changed year-over-year from $112.3 million in Q4 2024, and down 87.14% quarter-over-quarter from $872.6 million in Q2 2025.
HUTCHMED (China) (HMDCF) Shares Outstanding (Diluted Average) (2014 - 2025) Analysis & Trends
HUTCHMED (China) (HMDCF) has 10 years of Shares Outstanding (Diluted Average) data on file, last reported at $112.2 million in Q4 2025.
- Shares Outstanding (Diluted Average) for Q4 2025 came in at $112.2 million, changed 0.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $112.2 million (changed 0.04% YoY), and the FY2025 annual result was $112.2 million, changed 0.04% from the prior year.
- Shares Outstanding (Diluted Average) retreated to $112.2 million in Q4 2025 per HMDCF's latest filing, from $872.6 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $872.6 million in Q2 2025 and troughed at $140.0 in Q2 2021.
- A 5-year average of $182.3 million and a median of $111.2 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
- On a YoY basis, Shares Outstanding (Diluted Average) climbed as much as 681.79% in 2025 and fell as far as 0.04% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $101.8 million in 2021, then climbed by 6.42% to $108.3 million in 2022, then rose by 2.72% to $111.2 million in 2023, then grew by 0.93% to $112.3 million in 2024, then decreased by 0.04% to $112.2 million in 2025.
- Business Quant data shows HMDCF's Shares Outstanding (Diluted Average) at $112.2 million in Q4 2025, $872.6 million in Q2 2025, and $112.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | HUTCHMED (China) | - | - | - | 112.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 112.23 Mn |
| Jun 30, 2025 | 872.56 Mn |
| Dec 31, 2024 | 112.27 Mn |
| Jun 30, 2024 | 111.61 Mn |
| Dec 31, 2023 | 111.24 Mn |
| Jun 30, 2023 | 110.59 Mn |
| Dec 31, 2022 | 108.30 Mn |
| Dec 31, 2021 | 101.76 Mn |
| Jun 30, 2021 | 140.00 |
| Dec 31, 2018 | 66.43 Mn |
| Jun 30, 2018 | 490.00 |
| Dec 31, 2017 | 430.00 |
| Jun 30, 2017 | 30.00 |
| Dec 31, 2016 | 200.00 |
| Jun 30, 2016 | 10.00 |
| Dec 31, 2015 | 54.66 Mn |
| Jun 30, 2015 | 53.17 Mn |
| Dec 31, 2014 | 52.56 Mn |